Tumor necrosis factor priming of peripheral blood neutrophils from rheumatoid arthritis patients

Journal of Clinical Immunology

Volumn 16, Issue 4, 1996, Pages 216-221

  Kowanko, I C ^a,c   Ferrante, A ^a   Clemente, G ^a   Youssef, P P ^b   Smith, M ^b  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Cartilage injury; Neutrophil; Pathogenesis; Priming; Receptor; Respiratory burst; Rheumatoid arthritis; Superoxide; Tumor necrosis factor

Indexed keywords

SUPEROXIDE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CARTILAGE DEGENERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; MALE; NEUTROPHIL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CARTILAGE; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; RECEPTORS, TUMOR NECROSIS FACTOR; RESPIRATORY BURST; SUPEROXIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030005439     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01541227     Document Type: Article

References (41)

1. Figari IS, Mori NA, Palladino MA Jr: Regulation of neutrophil migration and superoxide production by recombinant tumor necrosis factors-α and -β: Comparison to recombinant interferon γ and interleukin-1α. Blood 70:979-984, 1987
2. Ferrante A, Nandoskar M, Walz A, Goh DHB, Kowanko IC: Effects of tumour necrosis factor alpha and interleukin-1 alpha and beta on human neutrophil migration, respiratory burst and degranulation. Int Arch Allergy Appl Immunol 86:82-91, 1988
3. Klebanoff SJ, Vadas MA, Harlan JM, Sparks LH, Gamble JR, Agosti JM, Waltersdorph AM: Stimulation of neutrophils by tumor necrosis factor. J Immunol 136:4220-4225, 1986
4. Nathan CF: Neutrophil activation on biological surfaces: massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest 80:1550-1560, 1987
5. Shalaby MR, Aggarwal BB, Rinderknecht E, Svedersky LP, Finkle BS, Palladino MA Jr: Activation of human polymorphonuclear neutrophil functions by interferon γ and tumor necrosis factors. J Immunol 135:2069-2073, 1985
6. Tsujimoto MS, Yokota S, Vilcek J, Weissman G: Tumor necrosis factor provokes Superoxide anion generation from neutrophils. Biochem Biophys Res Commun 137:1094-1100, 1986
7. Kowanko IC, Bates EJ, Ferrante A: Neutrophil-mediated cartilage injury in vitro is enhanced by tumour necrosis factor alpha. Rheumatol Int 10:85-90, 1990
8. Ferrante A, Martin AJ, Bates EJ, Kowanko IC, Harvey DP, Parsons D, Rathjen DA, Russ G, Dayer JM: Interaction of Staphylococcus aureus with human neutrophils and the down-regulation of TNF receptors. J Immunol 152:3998-4004, 1994
9. Djeu JY, Blanchard DK, Halkias H, Friedman H: Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: Activation by interferon-γ and tumour necrosis factor. J Immunol 137:2980-2984, 1986
10. Diamond RD, Lyman CA, Wysong DR: Disparate effects of interferon-γ and tumor necrosis factor-α on early neutrophil respiratory burst and fungicidal responses to Candida albicans in vitro. J Clin Invest 87:711, 1991
11. Hohman HP, Remy R, Brockhaus M, van loon APGM: Two different cell types have different major receptors for human tumor necrosis factor (TNF-α). J Biol Chem 264:14927-14934, 1989
12. Ding AH, Porteu F: Regulation of tumor necrosis factor receptors on phagocytes. Proc Soc Exp Biol Med 200:458-465, 1992
13. Schlieffenbaum B, Fehr J: The tumor necrosis factor receptor and human neutrophil function. Deactivation and cross-deactivation of tumor necrosis factor-induced neutrophil responses by receptor down-regulation. J Clin Invest 86:184-195, 1990
14. Porteu F, Nathan C: Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med 172:599-607, 1990
15. Saxne T, Palladino MA, Heinegard D, Talal N, Wollheim FA: Detection of tumor necrosis factor a but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum. Arth Rheum 31:1041-1045, 1988
16. Zangerle PF, DeGroote D, Lopez M, Meuleman RJ, Vrindts Y, Fauchet F, Dehart I, Jadoul M, Radoux D, Franchimont P: Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood. II Application to rheumatoid arthritis and osteoarthritis. Cytokine 4:568-575, 1992
17. Vreugdenhil G, Lowenberg B, van Eijk HG, Swaak JG: Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis. Eur J Clin Invest 22:488-493, 1992
18. Borzi RM, Arfilli L, Focherini MC, Pulsatelli L, Meliconi R: Circulating tumor necrosis factor alpha in rheumatoid arthritis. Boll Soc Ital Biol Sper 69:39-43, 1993
19. Zubler RH, Nydegger V, Perrin LH, et al.: Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. J Clin Invest 57:1038, 1976
20. Goddard DH, Brown KA, Kirk AP, McCarthy D, Johnson GD, Holborrow EJ: Immunoglobulin inclusions in rheumatoid arthritis polymorphonuclear cells: Lack of correlation with circulating immune complexes. Rheumatol Int 2:27-30, 1982
21. Ferrante A, Thong YH: Separation of mononuclear cells from human blood is dependent on blood column height. J Immunol Methods 48:81-85, 1982
22. Ferrante A, Seow WK, Rowan-Kelly B, Thong YH: Tetrandine, a plant alkaloid, inhibits the production of tumor necrosis alpha (cachectin) by human monocytes. Clin Exp Immunol 80:257-262, 1990
23. Kowanko IC, Ferrante A, Harvey DP, Carman KL: Granulocyte-macrophage colony-stimulating factor augments neutrophil killing of Torulopsis glabrata and stimulates neutrophil respiratory burst and degranulation. Clin Exp Immunol 83:225-230, 1991
24. Brennan FM, Maini RN, Feldmann M: TNFα - A pivotal role in rheumatoid arthritis? Br J Rheumatol 31:293-298, 1992
25. Mohr W, Pelster B, Wessinghage D: Polymorphonuclear granulocytes in rheumatic tissue destruction. Rheumatol Int 5:39-44, 1984
26. Velvart M, Fehr K: Degradation in vivo of articular cartilage in rheumatoid arthritis and juvenile chronic arthritis by cathepsin G and elastase from polymorphonuclear leukocytes. Rheumatol Int 7:195-202, 1987
27. Brown KA: The polymorphonuclear cell in rheumatoid arthritis. Br J Rheumatol 27:150-155, 1988
28. Kowanko IC, Bates EJ, Ferrante A: Mechanisms of human neutrophil-mediated cartilage damage in vitro: The role of lysosomal enzymes, hydrogen peroxide and hypochlorous acid. Immunol Cell Biol 67:321-329, 1989
29. Ferrante A, Kowanko IC, Bates EJ: Mechanisms of host tissue damage by cytokine-activated neutrophils. In Granulocyte Responses to Cytokines: Basic and Clinical Research, RG Coffey (ed). New York, Marcel Dekker, 1992, pp 499-521
30. Turner RA, Johnson JA, Turner SR: Neutrophil responsiveness to chemoattractant tripeptide in rheumatoid arthritis. Proc Soc Exp Biol Med 186:125-133, 1987
31. Berliner S, Fried M, Caspi D, Weinberger A, Yaron M, Pinkhas J, Aronson M: Evaluation of disease activity in rheumatic patients by leucocyte adhesiveness/aggregation. Ann Rheum Dis 47:458-462, 1988
32. McCarthy DA, Bernhagen J, Taylor MJ, Hamblin AS, James I, Thompson PW, Perry JD: Morphological evidence that activated polymorphs circulate in the peripheral blood of patients with rheumatoid arthritis. Ann Rheum Dis 51:13-18, 1992
33. Jobin C, Kreis C, Gauthier J, LeTarte J, Beaulieu AD: Differential synthesis of 5-lipoxygenase in peripheral blood and synovial fluid neutrophils in rheumatoid arthritis. J Immunol 146:2701-2707, 1991
34. Sheehan NJ, Brown KA, Perry JD, Chasty RC, Yates DA, Dumonde DC: Adherence of rheumatoid polymorphonuclear cells (PMNs) to cultured endothelial cell monolayers. Ann Rheum Dis 46:93-97, 1987
35. Dewar CL, Harth M: Superoxide production from cytokine-treated adherent rheumatoid neutrophils. Clin Invest Med 17:52-60, 1994
36. Chu CQ, Field M, Feldmann M, Maini RN: Localisation of tumour necrosis factor α in synovial tissues and the cartilage pannus junction in patients with rheumatoid arthritis. Arth Rheum 34: 1125-1132, 1991
37. Husby G, Williams RC Jr: Synovial localisation of tumour necrosis factor in patients with rheumatoid arthritis. J Autoimmun 1:363-371, 1988
38. Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, MacFarlane JD, Bijl H, Woody JN: Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105-1110, 1994
39. Williams RO, Feldmann M, Maini RN: Anti-tumour necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci USA 89:9784-9788, 1992
40. Issekutz AC, Meager A, Otterness I, Issekutz TB: The role of tumor necrosis factor-alpha and IL-1 in polymorphonuclear leucocyte and T-lymphocyte recruitment to joint inflammation in adjuvant arthritis. Clin Exp Immunol 97:26-32, 1994
41. Fava RA, Gates C, Townes AS: Critical role of peripheral blood phagocytes and the involvement of complement in tumour necrosis factor enhancement of passive collagen-arthritis. Clin Exp Immunol 94:261-266, 1993